News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SQI Diagnostics to Extend Warrant Expiry Date


7/31/2012 9:53:56 AM

TORONTO--(BUSINESS WIRE)--SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, announced today that it has received approval from the TSX Venture Exchange to extend the expiry of 1,140,000 outstanding common share purchase warrants (the “Warrants”) of the Company, which were issued in connection with the Company’s August 12, 2010 private placement financing.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES